-
Our fight against Covid-19CanSinoBIO is dedicated to establishing mass immune protection to the global population in a timely manner by working around the clock to develop the single-shot COVID-19 vaccine Convidecia.
-
Our main focus is innovative and high-quality vaccine for human useOur goal is to promote the development and commercialization of our vaccine products and contribute to improving the quality of public health worldwide.
-
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine in ChinaCanSino Biologics Inc. announced that the National Medical Products Administration of China granted conditional marketing authorization for its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (“Ad5-nCoV”, trade name: Convidecia™), making it the first of its kind authorized in China.
Development And Product
At CanSinoBIO, our main research and development focus is vaccines.
![](/upload/htm_static/image/kxnpro_1.jpeg)
Areas Of Focus
We apply our expertise across a range targets from antigen discovery, antigen overexpression, purification and formulation to proof-of-concept pre-clinical evaluation, production process development and assay development.
![](/upload/htm_static/image/kxnpro_2.jpeg)
Pipeline
We have an impressive array of vaccine candidates currently undergoing pre-clinical studies including recombinant protein-based pneumococcal vaccines, adenovirus-based recombinant TB vaccines, and polyvalent conjugate vaccines.
![](/upload/htm_static/image/kxnpro_3.jpeg)
Technology Platform
Our team works with world’s most advanced equipment and lab resources for microbiology, molecular cell biology, immunology and biochemistry. We also maintain top- notch animal research facilities.
Investors
We apply our expertise across a range targets from antigen discovery, antigen overexpression,
purification and formulation to proof-of-concept pre-clinical evaluation,
production process development and assay development.
purification and formulation to proof-of-concept pre-clinical evaluation,
production process development and assay development.